@NazishKhan23 Profile picture

Nazish Khan

@NazishKhan23

Consultant Pharmacist CVD & CV Clinical Research (QEHB/UHB), CVD Clinical & Programme Lead (Health Innovation Network)

Joined August 2023
Nazish Khan Reposted

Associations of iron deficiency with cardiac function, congestion, exercise capacity and prognosis in heart failure In HF outpatients, TSAT <20% is more consistently associated with congestion by ultrasound and poorer functional capacity onlinelibrary.wiley.com/doi/full/10.10…

Tweet Image 1

Nazish Khan Reposted

Lipoprotein(a) is an independent predictor for long-term in-stent restenosis and should be considered in the evaluation of patients undergoing PCI. academic.oup.com/eurjpc/article… @escardio @AboyansV @SilCastelletti @PeroneFrancesco @andreagallardo #cvprev

Tweet Image 1

Nazish Khan Reposted

The heart failure virtual ward and its cost-effectiveness. More on this model in bit.ly/3AAyvsn #EHJQCCO #HF #CVD @cpgale3 @diogoasantosfer @adamtimmis

Tweet Image 1

Nazish Khan Reposted

📚 Trends in population attributable fraction of modifiable risk factors for cardiovascular diseases across three decades ✏️ 𝟲 modifiable risk factors to population-level global CVD risk ⬇️ over time ✏️ However still account for 39% of total CVD in last decade ❤️‍🔥 ✏️…

Tweet Image 1

Nazish Khan Reposted

Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial possible signal of enhanced absolute treatment benefit with finerenone in this population requires further confirmation in future studies jacc.org/doi/10.1016/j.…

Tweet Image 1

Nazish Khan Reposted

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline For adults at high risk of CKD progression and complications, we recommend administering SGLT-2 inhibitors (strong recommendation ) bmj.com/content/387/bm…

Tweet Image 1

Nazish Khan Reposted

Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure semaglutide appeared to improve adverse cardiac remodeling compared with placebo, jacc.org/doi/10.1016/j.…

Tweet Image 1

Nazish Khan Reposted

Recent updates from #FINEARTSHF from virtual #HFSA2024 #LBCT sessions (🖇️below) 💥Benefits within 1 mo of initiation 💥Projected event-free survival gains by up to 3yrs 💥Pts with LVEF>60% & already treated w SGLTi consistently benefit 💥Benefits when started in any care setting

Tweet Image 1

Nazish Khan Reposted

‘’#CardiovascularDisease holds up a mirror to catastrophic inequalities around the world; deadly disparities persist and citizens are paying with their lives due to the lack of policy action for #CardiovascularHealth. On this #WorldHeartDay, I call for action which addresses…

Tweet Image 1

Nazish Khan Reposted

Early bird registration closes tomorrow! Last chance to get discounted tickets. Secure your place here: bshevents.eventsair.com/annual-meeting #25in25 #FindMe #BSHAM24

Tweet Image 1

Nazish Khan Reposted

For #WorldHeartDay come and join us in Birmingham for our Heart Health event if you are experiencing: Breathlessness Exhaustion Ankle swelling Time to come to the event and get checked because these could be signs of Heart Failure. #HeartFailure #BeatHF #FoundYou

Tweet Image 1

Nazish Khan Reposted

Why is measuring spending on prevention important? What is the role of place-based approaches to prevention? Our event in October will be delving into these questions and more, explore the full programme on our website. kingsfund.org.uk/events/support… #KFPrevention


Nazish Khan Reposted

🔥Outstanding and timely review on Obesity and Weight Loss Strategies for Patients With HF by @NutritionHF and colleagues @JACCJournals #JACCHF jacc.org/doi/10.1016/j.…

Tweet Image 1

Nazish Khan Reposted

#ESCCongress2024 ESC Geoffrey Rose Lecture on Prevention of Cardiovascular Disease by Prof John Deanfield Current medical model caters to diseases after years or even decades of exposure to CV harms Need a new paradigm to improve population health starting in childhood

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Nazish Khan Reposted

Intensive early and sustained lowering of non-high-density #lipoprotein #cholesterol after #myocardial infarction and prognosis: the SWEDEHEART registry released at #ESCCongress and just published in #EHJ👉 bit.ly/4dIWrb3 @ehj_ed

Tweet Image 1

Nazish Khan Reposted

Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial. Just published in the EHJ Fast Track Congress Section. @ESCCongress #AVR #AorticStenosis @ESC_Journals doi.org/10.1093/eurhea…

Tweet Image 1

Nazish Khan Reposted

🔥 fresh SoA review 🔥 @JACCJournals To supplement discussion of #MRA @ESCardioNews @escardio We comprehensively examine the current evidence regarding MRAs for HF and the future direction of nonsteroidal MRA research while exploring the causes of MRA underutilization.…

Tweet Image 1

Nazish Khan Reposted

🔥 A new therapeutic era in #HFpEF #FINEARTSHF with definitive evidence supporting the role of the non-steroidal MRA finerenone at #ESCCongress Now in @NEJM nejm.org/doi/full/10.10…

Tweet Image 1

Nazish Khan Reposted

GLP-1 RA reduces CV events & CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes Our most comprehensive analysis yet, #simpub in @CircAHA for #ESCCongress ahajournals.org/doi/abs/10.116…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Nazish Khan Reposted

ABYSS trial showed interrupting B-blocker in MI with preserved LVEF > 40% is not different from continuing B-blockers with regards to composite of death, MI, stroke, or CV hospitalization. Interrupting B-blockers resulted in higher hospitalization rate #ESCCongress #cardiology

Tweet Image 1

United States Trends
Loading...

Something went wrong.


Something went wrong.